PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors
MENLO PARK, Calif., Dec. 11, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that David Botstein, Ph.D., a member of PacBio’s Board of Directors, has retired from his position effective December 7, 2023.
Related news for (PACB)
- MoBot alert highlights: NASDAQ: IMCC, NASDAQ: BIAF, NASDAQ: HOLO, NYSE: JOBY, NASDAQ: PACB (05/28/25 02:00 PM)
- Breaking News: MoBot’s Latest Update as of 04/09/25 09:00 AM
- Today’s Top Performers: MoBot’s Market Review 02/14/25 09:00 AM
- PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
- PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024